LUCID GROUP PARTNERS WITH NEW INVESTOR ICG
March 10, 2021 | Lucid, Medical Communications, investment
Lucid Group has secured a new investment from Intermediate Capital Group (ICG) to support its continued ambition to build a global business that delivers life transforming value for everyone.
Founded in 2007, Lucid Group is a strategic healthcare communications company committed to advancing patient health outcomes through healthcare communications that improve the way patients and diseases are managed, and medicines are used. Lucid Group’s pioneering approaches have received industry-wide recognition and have consistently led to above industry growth.
With offices in the UK, US and Asia, Lucid now employs around 250 people. Lucid works in partnership with the world’s leading pharmaceutical and biotech organisations and has played a pivotal role in providing healthcare communication solutions for many of the industry’s innovative blockbuster assets.
LDC will exit after nearly four successful years during which Lucid has completed two successful acquisitions – HealthCare21 and Bluedog – strengthening its digital, creative and scientific offering, expanding its high-profile client base and significantly strengthening its team and operations. Lucid also expanded internationally, launching into new markets in Singapore and Dubai and adding to its established presence in the US. These accomplishments, with LDC’s support, have enabled Lucid to reach key milestones in the first phase of its ambitious growth plans.
ICG brings deep healthcare sector expertise, a global network and significant availability of additional capital to support Lucid on its journey. ICG will support Lucid’s ambitious team to acquire and build new capabilities that will add value to its clients, attract new talent and evolve its people development offering. They will also support further expansion across geographies, with a particular focus on the US.
On securing this investment Dennis O’Brien, Lucid Group CEO, commented, “This marks the start of an exciting new chapter for Lucid, which drives increased investment to help us realise our vision of transforming lives. We have a tremendous team and a great client base, our goal is to continue to strengthen this by bringing new capabilities and more value to our partnerships. With ICG we feel we have the perfect partner who shares our vision and matches our level of ambition to transform the value we bring to our industry and to patients. ICG are deeply committed to investing in this sector and are perfectly positioned to help bring the best capabilities to our business and support us to further internationalise.”
Peter Kirtley, ICG Managing Director, commented, “ICG is a leading global alternative asset manager, with a long and successful track record of providing capital to support founder-led growing businesses like Lucid Group. We have admired Lucid Group and its reputation within the industry for many years. Through our partnership, together, we can leverage Lucid’s ambition and our sector expertise to build a truly global healthcare communications organisation.”
For more information please contact:
Laura Gaskell, Marketing Director
Email: laura.gaskell@wearelucidgroup.com
This content was provided by Lucid Group Communications Limited
Company Details
Latest Content from Lucid Group Communications Limited
My Journey Into MedComms #LucidLife
In NetworkPharma’s latest career guide for wannabe account managers, Tessa Rowland, Senior Account Executive, discusses her journey into the varied and fast-paced world of medical communications.
Lucid Group bolster its talent with a further twelve new starters for 2021
As if welcoming eight new graduates was not enough to bring some excitement to the start of the new year, Lucid Group has also welcomed a further twelve new employees...
The Lucid Group Futures Academy welcomes its 2021 cohort
This week Lucid welcomed its newest cohort of graduates onto the 2021 Futures Academy programme. The programme provides graduates with a 12-month structured medical writing training programme. It’s a chance...
Our People and their Growth are at the heart of #LucidLife
2020 has been a year like no other, in more ways than one. We wanted to shine a light on the good and great of 2020 and reflect on far...
Advance Outcomes named of the most innovative strategies of 2020 by PM360
PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Lucid Group’s pioneering behaviour-change methodology, Advance OutcomesTM, as one of...
Lucid Group Evolve and Simplify its Brand Architecture
The current pandemic has forced many industries to find new ways of working. Within medical communications (medcomms), this has involved pivoting quickly towards a digital-first approach in order to optimise...
Laurence Bannister joins Lucid Group as its new Chief Commercial Officer
Laurence brings a track record of success from 22 years’ experience in pharmaceuticals/healthcare – across affiliate, regional and global commercial roles – with the last 9 years being at STEM...
A Lucid Group Thirsty Thursday: change management and self-efficacy
Last week, Lucid Group were lucky enough to have Richard Nugent, Founder and Managing Director of TwentyOne Leadership, present a session on change management and self-efficacy. Richard often works with...
Lucid Group expand its UK office footprint in Macclesfield
Lucid Group is increasing its share of office space on the popular Tytherington Business Village, after a sustained period of growth, which has seen it outperform a buoyant marketplace and taken...
Lucid Group are keeping wellness front of mind
It's important to make sure that people are supported and encouraged to practice self-care throughout the year. This is why Lucid Group has been reminding its teams of the LucidBeing...